BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10720059)

  • 1. A human pituitary tumor-derived folliculostellate cell line.
    Danila DC; Zhang X; Zhou Y; Dickersin GR; Fletcher JA; Hedley-Whyte ET; Selig MK; Johnson SR; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1180-7. PubMed ID: 10720059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin effects on neoplastic proliferation of human pituitary tumors.
    Danila DC; Inder WJ; Zhang X; Alexander JM; Swearingen B; Hedley-Whyte ET; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1009-15. PubMed ID: 10720031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activin subunit, follistatin, and activin receptor gene expression in the prepubertal female rat pituitary.
    Wilson ME; Handa RJ
    Biol Reprod; 1998 Aug; 59(2):278-83. PubMed ID: 9687296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.
    Danila DC; Zhang X; Zhou Y; Haidar JN; Klibanski A
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4741-6. PubMed ID: 12364468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes.
    Sidis Y; Fujiwara T; Leykin L; Isaacson K; Toth T; Schneyer AL
    Biol Reprod; 1998 Oct; 59(4):807-12. PubMed ID: 9746729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta regulates pituitary follistatin and inhibin/activin betaB mRNA levels and attenuates FSH secretion in response to activin-A.
    Bilezikjian LM; Turnbull AV; Corrigan AZ; Blount AL; Rivier CL; Vale WW
    Endocrinology; 1998 Jul; 139(7):3361-4. PubMed ID: 9645713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
    Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of a simian virus 40-transformed, temperature-sensitive rat antimesometrial decidual cell line.
    Srivastava RK; Gu Y; Zilberstein M; Ou JS; Mayo KE; Chou JY; Gibori G
    Endocrinology; 1995 May; 136(5):1913-9. PubMed ID: 7720638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization and mRNA expression of activin, inhibin, follistatin, and activin receptor in bovine cumulus-oocyte complexes during in vitro maturation.
    Izadyar F; Dijkstra G; Van Tol HT; Van den Eijnden-van Raaij AJ; Van den Hurk R; Colenbrander B; Bevers MM
    Mol Reprod Dev; 1998 Feb; 49(2):186-95. PubMed ID: 9444661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling.
    Zhou Y; Sun H; Danila DC; Johnson SR; Sigai DP; Zhang X; Klibanski A
    Mol Endocrinol; 2000 Dec; 14(12):2066-75. PubMed ID: 11117535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine regulation of FSH by follistatin in folliculostellate cell-enriched primate pituitary cell cultures.
    Kawakami S; Fujii Y; Okada Y; Winters SJ
    Endocrinology; 2002 Jun; 143(6):2250-8. PubMed ID: 12021189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of activin A and follistatin core proteins by human prostate tumor cell lines.
    McPherson SJ; Mellor SL; Wang H; Evans LW; Groome NP; Risbridger GP
    Endocrinology; 1999 Nov; 140(11):5303-9. PubMed ID: 10537161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
    Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
    Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line.
    Ying C; Zhang Z; Huang G; Li SQ; Ying SY
    J Endocrinol Invest; 1996 Jan; 19(1):6-11. PubMed ID: 8851685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1).
    Wang QF; Khoury RH; Smith PC; McConnell DS; Padmanahban V; Midgley AR; Schneyer AL; Crowley WF; Sluss PM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1434-41. PubMed ID: 8636347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle.
    Halvorson LM; Weiss J; Bauer-Dantoin AC; Jameson JL
    Endocrinology; 1994 Mar; 134(3):1247-53. PubMed ID: 8119165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat anterior pituitary folliculostellate cells are targets of interleukin-1beta and a major source of intrapituitary follistatin.
    Bilezikjian LM; Leal AM; Blount AL; Corrigan AZ; Turnbull AV; Vale WW
    Endocrinology; 2003 Feb; 144(2):732-40. PubMed ID: 12538636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.